McGlashan et al. studied 49 LPR patients who were divided into a group which was provided with a suspension of alginate and a group which was given placebos.
Mc Glashan y cols realizaron un estudio en 49 pacientes con diagnóstico de RFL, donde a un grupo se le suministró una suspensión de alginato y al otro grupo placebo.